EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders

Friederike S David, Josef Frank, Frederike Stein, Susanne Meinert, Lea Zillich, Lea Sirignano, Fabian Streit, Eva C Beins, Lisa Sindermann, Paula Usemann, Janik Goltermann, Elisabeth J Leehr und 11 weitere

Comprehensive Psychiatry · 2025-11 · 143 · 152629

DOI: 10.1016/j.comppsych.2025.152629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2025-11. Verfasst von Friederike S David und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Department of Psychiatry and Psychothe…. Hauptthemen laut MEDLINE: DNA Methylation, Bipolar Disorder, Schizophrenia, Major Depressive Disorder. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rheinische Friedrich-Wilhelms-Universität Bonn, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations in DNA methylation (DNAm) profiles have been implicated in affective and psychotic disorders. However, no comprehensive understanding of peripheral DNAm profiles associated with diagnostic groups, course of illness, and other clinical variables has emerged yet. In particular, studies exploring commonalities and differences across diagnoses are lacking. Here we conducted a systematic epigenetic characterization of the transdiagnostic German FOR2107 cohort, including individuals with major depressive disorder (MDD, n = 342), bipolar disorder (BD, n = 99), or a schizophrenia spectrum disorder (SSD, n = 101) and healthy controls (HC, n = 339). For 183 MDD cases and 178 HC, we assessed additional DNAm data from the two-year follow-up study visit. To explore DNAm differences between and across diagnostic groups, case-control and case-case methylome-wide association studies were performed. Our sample was further characterized using methylation risk scores (MRS) for MDD and SSD. Finally, epigenetic age acceleration was examined and compared to a measure of brain age acceleration. We identified few methylome-wide significant associations with diagnostic groups. MRS for MDD did not differ between diagnostic groups, and an increase in MRS for SSD in SSD compared to HC did not remain significant when adjusting for smoking behavior and BMI. An increase in epigenetic age acceleration was most evident for SSD compared to HC, which did not remain significant when adjusting for covariates. No correlation between epigenetic and brain age acceleration was observed. Our findings emphasize the relevance of potential confounding factors in epigenetics research in psychiatry and contribute to a growing body of studies on DNAm profiles across affective and psychotic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationBipolar DisorderSchizophreniaMajor Depressive DisorderHumansFemaleAdultMaleCase-Control StudiesMiddle AgedEpigenesis, Genetic

Stichwörter der Autor:innen

Affective disordersDNA MethylationEpigenetic ageMWASSchizophrenia spectrum disorders

Autor:innen und Institutionen

  • Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
  • Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany; Center for Mind, Brain and Behavior, University of Marburg, Marburg, Germany.
  • Institute for Translational Psychiatry, University of Münster, Münster, Germany; Institute for Translational Neuroscience, University of Münster, Münster, Germany.
  • Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Hector Institute for Artificial Intelligence in Psychiatry, Centr…
  • Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Förderung

  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

David, F. S., Frank, J., Stein, F., Meinert, S., Zillich, L., Sirignano, L., Streit, F., Beins, E. C., Sindermann, L., Usemann, P., Goltermann, J., Leehr, E. J., Sivalingam, S., Herms, S., Hoffmann, P., Hahn, T., Witt, S. H., Alexander, N., Kircher, T., …, & Forstner, A. J. (2025). Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders. Comprehensive Psychiatry, 143, 152629. https://doi.org/10.1016/j.comppsych.2025.152629

Vancouver

David FS, Frank J, Stein F, Meinert S, Zillich L, Sirignano L, et al. Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders. Comprehensive Psychiatry. 2025;143:152629. doi:10.1016/j.comppsych.2025.152629

BibTeX
@article{David2025,
  author = {David, Friederike S and Frank, Josef and Stein, Frederike and Meinert, Susanne and Zillich, Lea and Sirignano, Lea and Streit, Fabian and Beins, Eva C and Sindermann, Lisa and Usemann, Paula and Goltermann, Janik and Leehr, Elisabeth J and Sivalingam, Sugirthan and Herms, Stefan and Hoffmann, Per and Hahn, Tim and Witt, Stephanie H and Alexander, Nina and Kircher, Tilo and Dannlowski, Udo and Rietschel, Marcella and Nöthen, Markus M and Forstner, Andreas J},
  title = {Blood-based DNA methylation profiles in major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders},
  journal = {Comprehensive Psychiatry},
  year = {2025},
  volume = {143},
  pages = {152629},
  doi = {10.1016/j.comppsych.2025.152629}
}
Kostenlos starten →